246 related articles for article (PubMed ID: 23878581)
41. [Immunohistologic detection of bullous pemphigoid antigen in malignant melanoma].
Hamm G; Reiss CJ
Dermatol Monatsschr; 1985; 171(12):788-92. PubMed ID: 3912222
[No Abstract] [Full Text] [Related]
42. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
43. Autoantibodies of non-inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes.
Imafuku K; Iwata H; Kamaguchi M; Izumi K; Natsuga K; Ujiie H; Nishie W; Shimizu H
Exp Dermatol; 2017 Dec; 26(12):1171-1174. PubMed ID: 28266727
[TBL] [Abstract][Full Text] [Related]
44. Autoimmune bullous skin diseases, pemphigus and pemphigoid.
Egami S; Yamagami J; Amagai M
J Allergy Clin Immunol; 2020 Apr; 145(4):1031-1047. PubMed ID: 32272980
[TBL] [Abstract][Full Text] [Related]
45. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
[TBL] [Abstract][Full Text] [Related]
46. Increase in antigenicity of basement membrane zone antigens in bullous pemphigoid.
Remy W
J Invest Dermatol; 1986 Aug; 87(2):294-5. PubMed ID: 3525690
[No Abstract] [Full Text] [Related]
47. Western blot analysis of the antigen in pemphigoid gestationis.
Kelly SE; Bhogal BS; Wojnarowska F; Whitehead P; Leigh IM; Black MM
Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774
[TBL] [Abstract][Full Text] [Related]
48. Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.
Wada M; Nishie W; Ujiie H; Izumi K; Iwata H; Natsuga K; Nakamura H; Kitagawa Y; Shimizu H
J Invest Dermatol; 2016 May; 136(5):938-946. PubMed ID: 26827765
[TBL] [Abstract][Full Text] [Related]
49. Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.
Izumi K; Nishie W; Mai Y; Wada M; Natsuga K; Ujiie H; Iwata H; Yamagami J; Shimizu H
J Invest Dermatol; 2016 Nov; 136(11):2201-2210. PubMed ID: 27424319
[TBL] [Abstract][Full Text] [Related]
50. Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus?
Shipman AR; Cooper S; Wojnarowska F
Clin Exp Dermatol; 2011 Apr; 36(3):267-9. PubMed ID: 20569254
[TBL] [Abstract][Full Text] [Related]
51. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
Ghohestani RF; Claudy A
Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
[No Abstract] [Full Text] [Related]
52. Collagenous transmembrane proteins: collagen XVII as a prototype.
Franzke CW; Tasanen K; Schumann H; Bruckner-Tuderman L
Matrix Biol; 2003 Jun; 22(4):299-309. PubMed ID: 12935815
[TBL] [Abstract][Full Text] [Related]
53. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain.
Lin MS; Fu CL; Giudice GJ; Olague-Marchan M; Lazaro AM; Stastny P; Diaz LA
J Invest Dermatol; 2000 Dec; 115(6):955-61. PubMed ID: 11121125
[TBL] [Abstract][Full Text] [Related]
54. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
[TBL] [Abstract][Full Text] [Related]
55. C-terminal truncation impairs glycosylation of transmembrane collagen XVII and leads to intracellular accumulation.
Franzke CW; Has C; Schulte C; Huilaja L; Tasanen K; Aumailley M; Bruckner-Tuderman L
J Biol Chem; 2006 Oct; 281(40):30260-8. PubMed ID: 16899459
[TBL] [Abstract][Full Text] [Related]
56. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
Nishie W
Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
[TBL] [Abstract][Full Text] [Related]
57. Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid.
Xu L; Robinson N; Miller SD; Chan LS
Immunol Lett; 2001 Jun; 77(2):105-11. PubMed ID: 11377704
[TBL] [Abstract][Full Text] [Related]
58. BP180 (type XVII collagen) and its role in cutaneous biology and disease.
Van den Bergh F; Giudice GJ
Adv Dermatol; 2003; 19():37-71. PubMed ID: 14626817
[TBL] [Abstract][Full Text] [Related]
59. Itch, eosinophils, and autoimmunity: a novel murine model of bullous pemphigoid.
Yancey KB
J Invest Dermatol; 2015 May; 135(5):1213-1215. PubMed ID: 25882461
[TBL] [Abstract][Full Text] [Related]
60. Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?
Foureur N; Descamps V; Lebrun-Vignes B; Picard-Dahan C; Grossin M; Belaich S; Crickx B
Eur J Dermatol; 2001; 11(3):230-3. PubMed ID: 11358730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
